 Evgenia Gerasimovskaya
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasa Vasorum | 12 | 2023 | 36 | 4.680 |
Why?
| | Endothelial Cells | 11 | 2023 | 874 | 2.330 |
Why?
| | Pulmonary Artery | 19 | 2023 | 1127 | 1.920 |
Why?
| | Neovascularization, Pathologic | 5 | 2020 | 286 | 1.570 |
Why?
| | Adenosine Triphosphate | 8 | 2020 | 500 | 1.300 |
Why?
| | Hypoxia | 7 | 2021 | 1199 | 1.070 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 3 | 2020 | 20 | 1.070 |
Why?
| | Cattle | 17 | 2023 | 946 | 1.030 |
Why?
| | Hypertension, Pulmonary | 6 | 2023 | 1957 | 0.930 |
Why?
| | Adventitia | 3 | 2023 | 42 | 0.910 |
Why?
| | Phosphatidylinositol 3-Kinases | 6 | 2020 | 382 | 0.820 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 9 | 0.810 |
Why?
| | Neovascularization, Physiologic | 3 | 2016 | 192 | 0.770 |
Why?
| | Vascular Remodeling | 3 | 2023 | 209 | 0.760 |
Why?
| | Butyrates | 1 | 2021 | 66 | 0.650 |
Why?
| | Proto-Oncogene Proteins c-akt | 6 | 2020 | 440 | 0.630 |
Why?
| | Cell Hypoxia | 8 | 2018 | 247 | 0.630 |
Why?
| | Adenosine | 2 | 2020 | 255 | 0.630 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 18 | 0.620 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.620 |
Why?
| | Endothelium | 1 | 2020 | 119 | 0.620 |
Why?
| | Lung | 9 | 2023 | 4106 | 0.620 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 153 | 0.600 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 125 | 0.590 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2020 | 167 | 0.550 |
Why?
| | Signal Transduction | 10 | 2020 | 5216 | 0.550 |
Why?
| | Fibroblasts | 10 | 2019 | 1025 | 0.530 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 425 | 0.510 |
Why?
| | Apyrase | 2 | 2018 | 27 | 0.480 |
Why?
| | 5'-Nucleotidase | 2 | 2018 | 49 | 0.470 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 209 | 0.450 |
Why?
| | Pneumonia | 1 | 2021 | 636 | 0.450 |
Why?
| | rhoA GTP-Binding Protein | 2 | 2019 | 76 | 0.430 |
Why?
| | Protein Kinases | 3 | 2007 | 312 | 0.430 |
Why?
| | Glycolysis | 1 | 2016 | 340 | 0.430 |
Why?
| | rho-Associated Kinases | 2 | 2019 | 82 | 0.430 |
Why?
| | Receptor, Adenosine A1 | 1 | 2013 | 11 | 0.390 |
Why?
| | Animals | 26 | 2023 | 38030 | 0.380 |
Why?
| | Actin Cytoskeleton | 1 | 2013 | 103 | 0.360 |
Why?
| | Antigens, CD | 2 | 2014 | 558 | 0.350 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 2187 | 0.340 |
Why?
| | Extracellular Space | 3 | 2009 | 117 | 0.340 |
Why?
| | Proto-Oncogene Proteins | 2 | 2004 | 624 | 0.340 |
Why?
| | Endothelium, Vascular | 5 | 2010 | 956 | 0.330 |
Why?
| | Receptors, Purinergic P2Y1 | 1 | 2010 | 8 | 0.330 |
Why?
| | Cell Communication | 2 | 2012 | 328 | 0.320 |
Why?
| | Macrophages | 3 | 2021 | 1507 | 0.320 |
Why?
| | Cell Proliferation | 10 | 2023 | 2507 | 0.310 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2018 | 36 | 0.310 |
Why?
| | Cells, Cultured | 10 | 2017 | 4148 | 0.290 |
Why?
| | TOR Serine-Threonine Kinases | 5 | 2020 | 454 | 0.280 |
Why?
| | Calcium Signaling | 1 | 2010 | 245 | 0.280 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2007 | 25 | 0.260 |
Why?
| | Cell Division | 3 | 2004 | 756 | 0.240 |
Why?
| | Enzyme Activation | 5 | 2017 | 762 | 0.210 |
Why?
| | Calcium | 1 | 2010 | 1190 | 0.210 |
Why?
| | Receptors, Purinergic | 2 | 2016 | 20 | 0.210 |
Why?
| | Cell Movement | 5 | 2017 | 959 | 0.210 |
Why?
| | Adenosine Diphosphate | 3 | 2018 | 83 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1996 | 0.200 |
Why?
| | Autocrine Communication | 1 | 2002 | 38 | 0.180 |
Why?
| | Immediate-Early Proteins | 1 | 2002 | 46 | 0.180 |
Why?
| | Paracrine Communication | 1 | 2002 | 67 | 0.180 |
Why?
| | Biology | 1 | 2023 | 88 | 0.180 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2524 | 0.170 |
Why?
| | Systole | 1 | 2021 | 181 | 0.170 |
Why?
| | Tight Junctions | 1 | 2021 | 82 | 0.170 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 149 | 0.160 |
Why?
| | Acetylation | 1 | 2021 | 259 | 0.160 |
Why?
| | Metabolic Diseases | 1 | 2021 | 114 | 0.160 |
Why?
| | Microvessels | 1 | 2021 | 97 | 0.160 |
Why?
| | Extracellular Fluid | 1 | 2020 | 38 | 0.160 |
Why?
| | Animals, Newborn | 2 | 2014 | 891 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 231 | 0.150 |
Why?
| | Rats | 3 | 2021 | 5584 | 0.150 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 270 | 0.150 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 93 | 0.140 |
Why?
| | Laminin | 2 | 2009 | 72 | 0.140 |
Why?
| | Up-Regulation | 1 | 2021 | 847 | 0.140 |
Why?
| | Proteoglycans | 2 | 2009 | 112 | 0.140 |
Why?
| | Metabolome | 1 | 2021 | 388 | 0.130 |
Why?
| | Neprilysin | 1 | 2017 | 47 | 0.130 |
Why?
| | rho GTP-Binding Proteins | 1 | 2017 | 56 | 0.130 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2018 | 104 | 0.130 |
Why?
| | Drug Combinations | 2 | 2009 | 396 | 0.130 |
Why?
| | Heart Ventricles | 1 | 2021 | 756 | 0.120 |
Why?
| | Vascular Diseases | 1 | 2019 | 252 | 0.120 |
Why?
| | Collagen | 2 | 2009 | 457 | 0.120 |
Why?
| | DNA | 3 | 2009 | 1435 | 0.120 |
Why?
| | Muscle Proteins | 1 | 2017 | 242 | 0.120 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1480 | 0.110 |
Why?
| | Male | 8 | 2020 | 72843 | 0.110 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2017 | 449 | 0.110 |
Why?
| | Blood Pressure | 1 | 2021 | 1779 | 0.110 |
Why?
| | Cell Migration Assays | 1 | 2014 | 4 | 0.100 |
Why?
| | Transcription Factors | 1 | 2002 | 1734 | 0.100 |
Why?
| | Myocardium | 1 | 2019 | 934 | 0.100 |
Why?
| | Colony-Forming Units Assay | 1 | 2014 | 95 | 0.100 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 49 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2020 | 1356 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2067 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2014 | 72 | 0.100 |
Why?
| | Chromones | 1 | 2013 | 43 | 0.100 |
Why?
| | Oxadiazoles | 1 | 2013 | 37 | 0.100 |
Why?
| | Blood Vessels | 2 | 2012 | 167 | 0.100 |
Why?
| | Inflammation | 2 | 2023 | 2878 | 0.090 |
Why?
| | Morpholines | 1 | 2013 | 130 | 0.090 |
Why?
| | Rats, Nude | 1 | 2012 | 25 | 0.090 |
Why?
| | Osteopontin | 1 | 2012 | 35 | 0.090 |
Why?
| | Fluoresceins | 1 | 2012 | 48 | 0.090 |
Why?
| | Humans | 18 | 2023 | 145475 | 0.090 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2011 | 36 | 0.090 |
Why?
| | Telomerase | 1 | 2014 | 246 | 0.090 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2012 | 196 | 0.080 |
Why?
| | Dextrans | 1 | 2011 | 84 | 0.080 |
Why?
| | Endothelin-1 | 2 | 2017 | 181 | 0.080 |
Why?
| | Capillary Permeability | 1 | 2011 | 132 | 0.080 |
Why?
| | Purinergic Agonists | 1 | 2010 | 4 | 0.080 |
Why?
| | Ribosomal Protein S6 | 1 | 2010 | 18 | 0.080 |
Why?
| | Pertussis Toxin | 1 | 2010 | 24 | 0.080 |
Why?
| | Pyridoxal Phosphate | 1 | 2010 | 20 | 0.080 |
Why?
| | Cyclic AMP | 1 | 2011 | 207 | 0.080 |
Why?
| | Azo Compounds | 1 | 2010 | 30 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 505 | 0.080 |
Why?
| | Airway Remodeling | 1 | 2011 | 63 | 0.080 |
Why?
| | Models, Biological | 2 | 2021 | 1764 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 135 | 0.080 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 333 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 171 | 0.080 |
Why?
| | Calcium Channels | 1 | 2010 | 157 | 0.080 |
Why?
| | Transport Vesicles | 1 | 2009 | 22 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 977 | 0.070 |
Why?
| | Regression Analysis | 1 | 2011 | 1001 | 0.070 |
Why?
| | Blotting, Western | 1 | 2011 | 1179 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2011 | 1300 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.070 |
Why?
| | Cell Line | 2 | 2012 | 2823 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1716 | 0.070 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 94 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 174 | 0.060 |
Why?
| | Connective Tissue | 1 | 2006 | 38 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2326 | 0.060 |
Why?
| | Nucleotides | 2 | 2002 | 129 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2007 | 552 | 0.050 |
Why?
| | Pulmonary Veins | 1 | 2006 | 107 | 0.050 |
Why?
| | Aorta | 1 | 2007 | 440 | 0.050 |
Why?
| | Oligonucleotides, Antisense | 1 | 2004 | 118 | 0.050 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2023 | 56 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2023 | 112 | 0.050 |
Why?
| | Sildenafil Citrate | 1 | 2023 | 60 | 0.050 |
Why?
| | Purinergic P2 Receptor Antagonists | 1 | 2002 | 11 | 0.050 |
Why?
| | Culture Media, Serum-Free | 1 | 2002 | 42 | 0.050 |
Why?
| | Early Growth Response Protein 1 | 1 | 2002 | 32 | 0.050 |
Why?
| | Reactive Oxygen Species | 2 | 2019 | 611 | 0.050 |
Why?
| | Growth Substances | 1 | 2002 | 138 | 0.050 |
Why?
| | Purines | 1 | 2023 | 187 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2002 | 159 | 0.040 |
Why?
| | Stem Cells | 3 | 2012 | 628 | 0.040 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2023 | 218 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 288 | 0.040 |
Why?
| | Vasodilator Agents | 1 | 2023 | 330 | 0.040 |
Why?
| | Biomarkers | 1 | 2012 | 4295 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2023 | 314 | 0.040 |
Why?
| | Ligands | 1 | 2021 | 665 | 0.040 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 81 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 63 | 0.040 |
Why?
| | Time Factors | 1 | 2009 | 7123 | 0.030 |
Why?
| | Immune System | 1 | 2019 | 180 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 2028 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 11 | 0.030 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 7 | 0.030 |
Why?
| | Fetus | 1 | 2002 | 804 | 0.030 |
Why?
| | Leukocytes | 1 | 2019 | 296 | 0.030 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 81 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 344 | 0.030 |
Why?
| | Oxygen | 1 | 2003 | 978 | 0.030 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 82 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2017 | 135 | 0.030 |
Why?
| | Phenotype | 2 | 2017 | 3155 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 221 | 0.030 |
Why?
| | Protein Binding | 1 | 2002 | 2238 | 0.030 |
Why?
| | MAP Kinase Signaling System | 2 | 2012 | 307 | 0.030 |
Why?
| | Actins | 1 | 2017 | 425 | 0.030 |
Why?
| | Cell Differentiation | 3 | 2011 | 2046 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 546 | 0.030 |
Why?
| | Mice | 1 | 2012 | 18329 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1061 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2018 | 534 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 1852 | 0.020 |
Why?
| | Integrin alphaVbeta3 | 1 | 2012 | 20 | 0.020 |
Why?
| | Cell Growth Processes | 1 | 2012 | 48 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2012 | 104 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 531 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 506 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3124 | 0.020 |
Why?
| | Vasculitis | 1 | 2011 | 69 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 919 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 443 | 0.020 |
Why?
| | Myofibroblasts | 1 | 2011 | 148 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1707 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5983 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2006 | 408 | 0.010 |
Why?
| | Pulmonary Circulation | 1 | 2006 | 430 | 0.010 |
Why?
| | Gene Silencing | 1 | 2004 | 202 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2006 | 372 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2006 | 562 | 0.010 |
Why?
| | Serotonin | 1 | 2003 | 297 | 0.010 |
Why?
| | Cell Survival | 1 | 2003 | 1100 | 0.010 |
Why?
| | Lung Diseases | 1 | 2006 | 780 | 0.010 |
Why?
| | Hypertension | 1 | 2006 | 1273 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2003 | 1131 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4560 | 0.010 |
Why?
| | Infant | 1 | 2002 | 10077 | 0.000 |
Why?
| | Child | 1 | 2002 | 22707 | 0.000 |
Why?
| | Adult | 1 | 2002 | 40777 | 0.000 |
Why?
|
|
Gerasimovskaya's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|